NCT01659138 Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis Status TERMINATED Phase PHASE2
NCT01658579 Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus on Basal Plus Mealtime Insulin Status COMPLETED Phase PHASE2
NCT01657214 Phase I, Dose Escalation of SAR125844 in Asian Solid Tumor Patients Status COMPLETED Phase PHASE1
NCT01652196 Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer Status COMPLETED Phase PHASE2
NCT01651143 Proof of Biological Activity of SAR100842 in Systemic Sclerosis Status COMPLETED Phase PHASE2
NCT01649635 Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer Status COMPLETED Phase PHASE4
NCT01646554 Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver Metastases Status WITHDRAWN Phase PHASE2/PHASE3
NCT01644474 Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe in Patients With Hypercholesterolemia Status COMPLETED Phase PHASE3
NCT01644188 Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe on Top of Statin in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY COMBO II) Status COMPLETED Phase PHASE3
NCT01644175 Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia (ODYSSEY COMBO I) Status COMPLETED Phase PHASE3
NCT01640860 Concurrent Chemoradiotherapy With Docetaxel and Cisplatin in Esophageal Cancer Status COMPLETED Phase N/A
NCT01639040 Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD) Status COMPLETED Phase PHASE2
NCT01632163 Assessment of the Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin +/- Metformin Status COMPLETED Phase PHASE3
NCT01630369 Efficacy and Safety of Insuman Basal/Comb/Rapid in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT01625494 Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine Monotherapy Status COMPLETED Phase PHASE3
NCT01623115 Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy Status COMPLETED Phase PHASE3
NCT01621776 Effect of Apidra Compared to Humalog in Decreasing Post-Prandial Hyperglycemia Status COMPLETED Phase NA
NCT01617655 Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia (ODYSSEY HIGH FH) Status COMPLETED Phase PHASE3